Skip to content
IV Infusion Allopathic

Carmustine 100 mg/vial iv infusion

Generic: Carmustine

Company: Renata PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength100 mg/vial
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated May 6, 2025.

Compare

Same generic, same strength

Sorted by price per iv infusion. Ask your pharmacist before you switch brands.

Carmustine 100 mg/vial iv infusions

Prices as listed on BestinMeds.

No price is listed for this strength yet.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Carmustine guide

Indications

Carmustine injection is indicated as palliative therapy as a single agent or in established combination therapy in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. Multiple myeloma in combination with prednisone. Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs. Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs.

Dosage and administration

Recommended Dosage: As a single agent, 150 to 200 mg/m2 carmustine intravenously every 6 weeks as a single dose or divided into daily injections such as 75 to 100 mg/m2 on 2 successive days. Adjust dose for combination therapy or in patients with reduced bone marrow reserve Administer reconstituted solution only as a slow intravenous infusion over at least 2 hours.

Side effects

Most common adverse reactions (>1%) are nausea, vomiting, renal toxicity, pneumonitis, pulmonary toxicity, myelosuppression

Precautions and warnings

Administration Reactions: Extravasation may occur; monitor infusion site closely during administration. Carcinogenicity: Potentially carcinogenic to humans. Monitor patient periodically for such signs and apprise the patient of the symptoms for which they need to seek medical help. Ocular Toxicity: Has occurred when administered via unapproved intraarterial intracarotid route. Embryo-Fetal toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and to avoid pregnancy.

Pregnancy and lactation

Pregnancy: Carmustine injection can cause fetal harm when administered to a pregnant woman based on the mechanism of action and findings in animals. Limited available data with Carmustine injection use in pregnant women are insufficient to inform a drug-associated risk of major birth defects and miscarriage. Carmustine was embryotoxic in rats and rabbits and teratogenic in rats (thoracoabdominal closure, neural tube, and eye defects and malformations of the skeletal system of the fetus) when given in doses lower than the maximum cumulative human dose based on body surface area. Consider the benefits and risks of Carmustine for the mother and possible risks to the fetus when prescribing Carmustine injection to a pregnant woman. Adverse outcomes in pregnancy occur regardless of the health of the mother or the use of medications. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. Lactation: There is no information regarding the presence of carmustine in human milk, the effects on the breastfed infant, or the effects on milk production. Because many drugs are excreted in human milk and because of the potential for serious adverse events (e.g., carcinogenicity and myelosuppression) in nursing infants, nursing should be discontinued while taking Carmustine.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250